Transcription of 薬剤耐性ワンヘルス動向調査年次報告書 2020
{{id}} {{{paragraph}}}
2020 Nippon AMR One Health Report (NAOR) 2020 1 .. 4 .. 5 .. 7 .. 10 .. 13 .. 14 .. 14 .. 14 .. 18 .. 23 .. 24 Mycobacterium tuberculosis .. 32 Clostridioides ( clostridium ) difficile .. 33 .. 33 .. 34 .. 36 .. 39 .. 39 .. 53 .. 55 .. 61 .. 62 .. 63 .. 67 .. 67 .. 72 .. 74 .. 75 .. 76 .. 76 .. 77 .. 77 .. 80 .. 90 .. 92 2 .. 92 .. 92 .. 93 .. 93 .. 94 .. 96 .. 97 (JANIS) .. 97 .. 97 .. 98 .. 98 (NESID).
CDI Clostridioides (Clostridium) difficile Infection クロストリディオイデス(クロストリジウム)・ディフィシル感染症 CLSI Clinical and Laboratory Standards Institute 米国臨床検査標準委員会 CRE Carbapenem-resistant Enterobacteriaceae カルバペネム耐性腸内細菌科細菌
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Clostridium difficile infection CDI, Difficile Infection, Difficile, Clostridioides(Clostridium)difficile感染症, Clostridium, Infection, Clostridium difficile, Clostridium difficile. infection CDI, PRESCRIBING INFORMATION, Microbiome, Clostridium difficile infection, Clostridium difficile感染症と院内感染対策について, Difficile infection CDI, GUIDELINES FOR TREATMENT OF CLOSTRIDIUM